Is there coercion or undue inducement to participate in health research in developing countries? An example from Rakai, Uganda

Journal of Clinical Ethics

Volumn 20, Issue 2, 2009, Pages 141-149

  Nalugoda, Fred ^a   Wagman, Jennifer ^b   Kiddugavu, Mohammed ^c   Kiwanuka, Noah ^d   Garrett, Elizabeth ^e   Gray, Ron H ^b   Serwadda, David ^f   Wawer, Maria J ^b   Emanuel, Ezekiel J ^g  

^a RAKAI HEALTH SCIENCES PROGRAM   (Uganda)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

^d MAKERERE UNIVERSITY   (Uganda)

^e MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^f MAKERERE UNIVERSITY SCHOOL OF PUBLIC HEALTH   (Uganda)

^g NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; DEVELOPING COUNTRY; ETHICS; FEMALE; HEALTH CARE DELIVERY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFORMED CONSENT; MALE; METHODOLOGY; MIDDLE AGED; PATIENT SELECTION; PERSUASIVE COMMUNICATION; RANDOMIZED CONTROLLED TRIAL; RESEARCH ETHICS; SEXUALLY TRANSMITTED DISEASE; SOUTH AFRICA; STATISTICS; TREATMENT REFUSAL; UGANDA;

ADOLESCENT; ADULT; COERCION; DEVELOPING COUNTRIES; ETHICS, RESEARCH; FEMALE; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HUMANS; INFORMED CONSENT; MALE; MIDDLE AGED; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; SEXUALLY TRANSMITTED DISEASES; SOUTH AFRICA; TREATMENT REFUSAL; UGANDA; YOUNG ADULT;

EID: 67650733891     PISSN: 10467890     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. S. Berkley, "Thorny issues in the ethics of AIDS vaccine trials," Lancet 362, no.9388 (2003): 992;
2. H.W. French, "AIDS research in Africa: juggling risks and hopes," New York Times, 9 October 1997, A1;
3. J. Stephens, "The body hunters: as drug testing spreads, profits and lives hang in balance," Washington Post, 17 December 2000, A1;
4. R.J. Rothman, "The shame of medical research," New York Review of Books, 30 November 2000.
5. N.A. Christakis, "The ethical design of an AIDS vaccine trial in Africa," Hastings Center Report 28 (1998): 31-37
6. S. LaFraniere, M.P. Flaherty, and J. Stephens, "The dilemma: submit or suffer," Washington Post, 19 December 2000, A1.
7. J.W. Berg et al., Informed consent: legal theory and clinical practice, 2nd ed. (New York: Oxford University Press, 2001), chap. 3.
8. R.R. Faden and T.L. Beauchamp, A history and theory of informed consent (New York: Oxford University Press, 1986), 339.
9. Office for Protection from Research Risks, Protecting human research subjects: institutional review board guidebook (Washington, D.C.: U.S. Government Printing Office, 1993), chap. 3, p. 44.
10. Q.A. Karim et al., "Informed consent for HIV testing in a South African hospital: is it truly informed and truly voluntary?" American Journal of Public Health 88 (1998): 637-640
11. R.S. Murthy et al., "Informed consent for a drug trial: a systematic study," NIMHANS Journal 6 (1988): 145-149
12. O. Benitez, D. Devaux, and J. Dausset, "Audiovisual documentation of oral consent: a new method of informed consent for illiterate populations," Lancet 359 (2002): 1406-1407
13. M.J. Wawer et al., "Incidence of HIV-1 infection in a rural region of Uganda," British Medical Journal 308 (1994): 171-173;
14. M.J. Wawer et al., "A randomized, community trial of intensive sexually transmitted disease control for AIDS prevention, Rakai, Uganda," AIDS 12 (1998): 1211-1225
15. D. Serwadda et al., "Slim disease: a new disease in Uganda and its association with HTLVm infection," Lancet 2 (1985): 849-852
16. United Nations Development Report 2000, http://hdr.undp.org/reports/ global/2002/en/indi cator/indicator.cfm?File=cty-f-UGA.html;
17. World Bank Group, World Development Indicators (New York: World Bank, 2002), http://www.worldbank.org/data.
18. See notes 7 and 8 above.
19. M.J. Wawer et al., "Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomized community trial," Lancet 353 (1999): 525-535
20. World Bank, see note 12 above.
21. Ibid.
22. "Code of Federal Regulations ,Title 45, Public Welfare, Department of Health and Human Services, Part 46, Protection of Human Subjects, Revised June 23, 2005, Effective June 23, 2005," http://www.hhs.gov/ohrp/ humansubjects/guidance/45cfr46.htm, accessed 12 March 2009.
23. World Bank, see note 12 above.
24. C.P. Gross et al., "Reporting the recruitment process in clinical trials: who are these patients and how did they get there?" Annals of Internal Medicine 137 (2002): 10-16
25. See note 14 above.
26. www.cdc.gov/genomics/population/publications/nhanes.htm
27. G.M. McQuillan et al., "Consent for genetic research in a general population: The NHANES experience," Genetics in Medicine 5 (January/February 2003): 35-42.
28. See note 7 above.
29. See note 6 above.
30. See notes 7 and 8 above.
31. See note 9 above;
32. World Bank, see note 12 above.